Intralipid as a Contrast Agent to Enhance Subsurface Blood Flow Imaging

Description:

This technology includes a blood flow imaging method that allows for a higher density of smaller particles to be detected. Current imaging methods that are based on Doppler measurements are limited by the discontinuity in the capillary flow in the space between red blood cells. The core technology is to use a scattering agent to enhance capillary flow or microcirculation. This technology has been tested for optical coherence Doppler tomography, but can be expended to any Doppler based flow imaging techniques such as laser speckle imaging. The fundamental discovery or idea is that in capillaries, red blood cells (RBC) are moving in a burst mode with high latency (large time gap between bursts). By injection of micro beads such as intralipid, the moving backscatterers will fill the gap and flow with RBCs. Since they are smaller, e.g., 1-3um, they are strong backscatterers that enhance backscattering signals and their motion with RBCs will enhance the Doppler detection (reduced latency).

Patent Information:
For Information, Contact:
Michael Shmilovich
Senior Licensing And Patenting Manager
NIH Technology Transfer
301-435-5019
shmilovm@nih.gov
Inventors:
Congwu Du
Yingtian Pan
Nora Volkow
Keywords:
© 2024. All Rights Reserved. Powered by Inteum